#AUA14 - Poster: An indirect treatment comparison and cost-effectiveness analysis of abiraterone acetate and enzalutamide for the treatment of metastatic castration-resistant prostate cancer post chemotherapy

ORLANDO, FL USA (UroToday.com) - Presented by Melissa Thompson,¹ Tracy Li,² Mary B. Todd,² Margaret K. Yu,⁴ Thian Kheoh,³ Jianming He,² and Ryan Saadi² at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

¹Cornerstone Research Group, Inc., Burlington, ON, Canada
²Janssen Global Services, LLC, Raritan, NJ USA
³Janssen Research & Development, Los Angeles, CA USA

Click HERE to read an exclusive report by a UroToday medical writer